UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 298

Sortiert nach

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy

Current medical research and opinion, 2010-01, Vol.26 (1), p.213-222

Neutel, J.M.

2010

Volltextzugriff (PDF)

Effect of the renin-angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function

Journal of human hypertension, 2004-09, Vol.18 (9), p.599-606

NEUTEL, J. M

2004

Volltextzugriff (PDF)

Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials

Journal of human hypertension, 2009-09, Vol.23 (9), p.610-619

2009

Volltextzugriff (PDF)

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Journal of human hypertension, 2010-01, Vol.24 (1), p.64-73

2010

Volltextzugriff (PDF)

Magnitude of the early morning blood pressure surge in untreated hypertensive patients: a pooled analysis

International journal of clinical practice (Esher), 2008-11, Vol.62 (11), p.1654-1663

2008

Volltextzugriff (PDF)

Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2001-09, Vol.3 (5), p.283-318

2001

Volltextzugriff (PDF)

A comparison of the efficacy and safety of irbesartan HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension

Journal of human hypertension, 2008-04, Vol.22 (4), p.266-274

2008

Volltextzugriff (PDF)

Bococizumab (rn316/pf-04950615), a monoclonal antibody against pcsk9 in statin-treated hypercholesterolemic subjects: Results from a randomized, placebo-controlled, dose-ranging study (nct: 01592240)

Atherosclerosis, 2014-08, Vol.235 (2), p.e75-e76

2014

Volltextzugriff (PDF)

Initial combination therapy for rapid and effective control of moderate and severe hypertension

Journal of human hypertension, 2009-01, Vol.23 (1), p.4-11

2009

Volltextzugriff (PDF)

Clinical studies of CS-866, the newest angiotensin II receptor antagonist

The American journal of cardiology, 2001-04, Vol.87 (8), p.37-43

Neutel, Joel M

2001

Volltextzugriff (PDF)

A Multicenter, 14-Week Study of Telmisartan and Ramipril in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

American journal of hypertension, 2006, Vol.19 (1), p.104-112

2006

Volltextzugriff (PDF)

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension

Journal of the American Society of Hypertension, 2016-07, Vol.10, p.e5-e6

2016

Volltextzugriff (PDF)

Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension

Journal of human hypertension, 2006-04, Vol.20 (4), p.255-262

2006

Volltextzugriff (PDF)

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

The New England journal of medicine, 2023-02, Vol.388 (5), p.395-405

2023

Volltextzugriff (PDF)

Low-dose combination therapy: an important first-line treatment in the management of hypertension

American journal of hypertension, 2001-03, Vol.14 (3), p.286-292

2001

Volltextzugriff (PDF)

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, 2021-10, Vol.27 (10), p.1825-1835

2021

Volltextzugriff (PDF)

Blunted Rise in Postprandial Blood Glucose Following Diabetes-Specific Oral Nutritional Supplement in Adults with Type 2 Diabetes

Journal of the Academy of Nutrition and Dietetics, 2022-10, Vol.122 (10), p.A91-A91

2022

Volltextzugriff (PDF)

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

Journal of the American College of Cardiology, 2001-01, Vol.37 (1), p.169-174

2001

Volltextzugriff (PDF)

Ambulatory Blood Pressure Comparison of the Anti-hypertensive Efficacy of Fixed Combinations of Irbesartan/hydrochlorothiazide and Losartan/hydrochlorothiazide in Patients with Mild-to-moderate Hypertension

Journal of international medical research, 2005-11, Vol.33 (6), p.620-631

2005

Volltextzugriff (PDF)

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Journal of human hypertension, 2010-06, Vol.24 (6), p.430-430

2010

Volltextzugriff (PDF)

Low-dose antihypertensive combination therapy: its rationale and role in cardiovascular risk management

American journal of hypertension, 1999-08, Vol.12 (8), p.73S-79S

Neutel, Joel M

1999

Volltextzugriff (PDF)

Diagnosis of mild hypertension by ambulatory blood pressure monitoring

Circulation (New York, N.Y.), 1994-11, Vol.90 (5), p.2291-2298

1994

Volltextzugriff (PDF)

Beyond the sphygmomanometric numbers: hypertension as a syndrome

American Journal of Hypertension, 2001-08, Vol.14 (8), p.250S-257S

Neutel, Joel M

2001

Volltextzugriff (PDF)

MON-P239: High Protein, Low Carbohydrate, 100% whey Based Enteral Formula is Associated with Lower Blood Glucose Response

Clinical nutrition (Edinburgh, Scotland), 2017-09, Vol.36, p.S266-S266

2017

Volltextzugriff (PDF)

Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension: a randomised ABPM study

Journal of human hypertension, 2003-08, Vol.17 (8), p.569-575

2003

Volltextzugriff (PDF)

1 – 25 von 298

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(275)
Mit Volltextzugriff
(272)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(159)
Science & Technology
(152)
Life Sciences & Biomedicine
(150)
Male
(116)
Female
(106)
Middle Aged
(99)
Hypertension - Drug Therapy
(94)
Biological And Medical Sciences
(91)
Medical Sciences
(85)
Cardiovascular System & Cardiology
(83)
Adult
(72)
Aged
(72)
Peripheral Vascular Disease
(58)
Hypertension
(57)
Blood Pressure - Drug Effects
(53)
Hypertension - Physiopathology
(51)
Antihypertensive Agents - Therapeutic Use
(47)
Cardiovascular System
(47)
Pharmacology. Drug Treatments
(46)
Antihypertensive Agents
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy

Effect of the renin-angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function

Antihypertensive efficacy of telmisartan vs ramipril over the 24-h dosing period, including the critical early morning hours: a pooled analysis of the PRISMA I and II randomized trials

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Magnitude of the early morning blood pressure surge in untreated hypertensive patients: a pooled analysis

Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension

A comparison of the efficacy and safety of irbesartan HCTZ combination therapy with irbesartan and HCTZ monotherapy in the treatment of moderate hypertension

Bococizumab (rn316/pf-04950615), a monoclonal antibody against pcsk9 in statin-treated hypercholesterolemic subjects: Results from a randomized, placebo-controlled, dose-ranging study (nct: 01592240)

Initial combination therapy for rapid and effective control of moderate and severe hypertension

Clinical studies of CS-866, the newest angiotensin II receptor antagonist

A Multicenter, 14-Week Study of Telmisartan and Ramipril in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring

Additivity of Nebivolol/Valsartan Single-Pill Combination Versus Other Single-Pill Combinations for Hypertension

Effects of a structured treatment algorithm on blood pressure goal rates in both stage 1 and stage 2 hypertension

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension

Low-dose combination therapy: an important first-line treatment in the management of hypertension

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Blunted Rise in Postprandial Blood Glucose Following Diabetes-Specific Oral Nutritional Supplement in Adults with Type 2 Diabetes

Contrasting clinical properties and exercise responses in obese and lean hypertensive patients

Ambulatory Blood Pressure Comparison of the Anti-hypertensive Efficacy of Fixed Combinations of Irbesartan/hydrochlorothiazide and Losartan/hydrochlorothiazide in Patients with Mild-to-moderate Hypertension

Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension

Low-dose antihypertensive combination therapy: its rationale and role in cardiovascular risk management

Diagnosis of mild hypertension by ambulatory blood pressure monitoring

Beyond the sphygmomanometric numbers: hypertension as a syndrome

MON-P239: High Protein, Low Carbohydrate, 100% whey Based Enteral Formula is Associated with Lower Blood Glucose Response

Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension: a randomised ABPM study

Suchergebnisse filtern